LONDON – Health technology artificial intelligence company Medopad has raised $28 million in Series A funding toward a target of $120 million. The company’s health care technology data-capture platform connects patients and health care professionals in real time, enabling patients to continuously capture data through a broad set of modules and connected devices, then transmitting the collected data to health care professionals. “We now have several amazing strategic investors in the business, which is a great achievement for us as we gear up for significant growth and scale our business,” said Dan Vahdat, CEO of Medopad, in a statement. “Managing population health is one of the greatest challenges for governments across the world; we are proud to be at the forefront of solving this problem.” By improving the communication between patients and healthcare professionals, Medopad enables proactive early intervention, operational efficiencies and cost savings. The platform uses artificial intelligence to analyze collected data and develop predictive insights to detect life-threatening medical conditions. The company’s primary customers include hospitals, pharma companies, insurance companies and governments. Medopad has also announced that it has appointed industry leaders Stuart Fletcher, former CEO of BUPA Group, and Simon MacKinnon, chairman of Sinophi Healthcare, as non-executive directors.
You are here: / / Medopad raises $28M, expands leadership